Searches , social queries for CENEGERMIN

Search references for CENEGERMIN. Phrases containing CENEGERMIN

See searches and references containing CENEGERMIN!

Searches containing CENEGERMIN

CENEGERMIN

  • Cenegermin

    • Pharmaceutical drug

    Cenegermin, sold under the brand name Oxervate, also known as recombinant human nerve growth factor, is a recombinant form of human nerve growth factor

    Cenegermin

    Cenegermin

  • Dompé Farmaceutici

    • Italian pharmaceutical company

    Anabasis product Cenegermin, an eye drop containing recombinant human nerve growth factor, as a treatment for neurotrophic keratitis. Cenegermin received fast

    Dompé Farmaceutici

    Dompé Farmaceutici

    Dompé_Farmaceutici

  • Braegen-02

    • Pharmaceutical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Braegen-02

    Braegen-02

    Braegen-02

  • Fosgonimeton

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Fosgonimeton

    Fosgonimeton

    Fosgonimeton

  • Sentinel

    • Topics referred to by the same term

    High Standard Manufacturing Company Sentinel, a brand name for the drug cenegermin Sentinel Offender Services, a for-profit probation company Sentinel Sound

    Sentinel

    Sentinel

  • Amivantamab

    • Monoclonal antibody

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Amivantamab

    Amivantamab

    Amivantamab

  • Asciminib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Asciminib

    Asciminib

    Asciminib

  • Neurotrophic factor receptor

    • Group of protein families

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Neurotrophic factor receptor

    Neurotrophic_factor_receptor

  • Testosterone

    • Primary male sex hormone

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Testosterone

    Testosterone

    Testosterone

  • Nerve growth factor

    • Mammalian protein found in humans

    receptor kinase A. Recombinant human nerve growth factor (rhNGF; named cenegermin) has been formulated as an eye drop (0.002%), receiving approval by the

    Nerve growth factor

    Nerve growth factor

    Nerve_growth_factor

  • Bevacizumab

    • Medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Bevacizumab

    Bevacizumab

  • Nilotinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Nilotinib

    Nilotinib

    Nilotinib

  • HER2

    • Mammalian protein found in humans

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    HER2

    HER2

    HER2

  • Selpercatinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Selpercatinib

    Selpercatinib

    Selpercatinib

  • Amitriptyline

    • Tricyclic antidepressant

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Amitriptyline

    Amitriptyline

    Amitriptyline

  • Insulin

    • Peptide hormone

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Insulin

    Insulin

    Insulin

  • Growth factor

    • Protein or other substance that stimulates cellular proliferation

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Growth factor

    Growth_factor

  • Tyrosine kinase inhibitor

    • Drug typically used in cancer treatment

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Tyrosine kinase inhibitor

    Tyrosine kinase inhibitor

    Tyrosine_kinase_inhibitor

  • Erythropoietin

    • Protein that stimulates red blood cell production

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Lipegfilgrastim

    • Pharmaceutical drug

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Lipegfilgrastim

    Lipegfilgrastim

  • FGF17

    • Protein-coding gene in the species Homo sapiens

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    FGF17

    FGF17

    FGF17

  • Icrucumab

    • Monoclonal antibody

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Icrucumab

    Icrucumab

  • BNN-20

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    BNN-20

    BNN-20

    BNN-20

  • Wnt signaling pathway

    • Group of signal transduction pathways involved in embryonic development

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Wnt signaling pathway

    Wnt_signaling_pathway

  • Cediranib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Cediranib

    Cediranib

    Cediranib

  • Dexamethasone

    • Corticosteroid medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Dexamethasone

    Dexamethasone

    Dexamethasone

  • Insulin-like growth factor 1

    • Protein found in humans

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Insulin-like growth factor 1

    Insulin-like growth factor 1

    Insulin-like_growth_factor_1

  • Becaplermin

    • Pharmaceutical drug

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Becaplermin

    Becaplermin

  • CCN family member 2

    • Protein found in humans

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    CCN family member 2

    CCN family member 2

    CCN_family_member_2

  • E2511

    • Pharmaceutical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    E2511

    E2511

  • Integrin

    • Transmembrane receptors involved in cellular adhesion and signalling

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Integrin

    Integrin

    Integrin

  • FGF4

    • Fibroblast growth factor gene

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    FGF4

    FGF4

    FGF4

  • EPHA6

    • Protein-coding gene in the species Homo sapiens

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    EPHA6

    EPHA6

    EPHA6

  • Anti-VEGF

    • Medication which blocks growth of blood vessels

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Anti-VEGF

    Anti-VEGF

    Anti-VEGF

  • Trastuzumab deruxtecan

    • Medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Trastuzumab deruxtecan

    Trastuzumab deruxtecan

    Trastuzumab_deruxtecan

  • Filgrastim

    • Medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Filgrastim

    Filgrastim

    Filgrastim

  • Keratinocyte growth factor

    • InterPro family

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Keratinocyte growth factor

    Keratinocyte_growth_factor

  • Brain-derived neurotrophic factor

    • Protein found in humans

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Brain-derived neurotrophic factor

    Brain-derived neurotrophic factor

    Brain-derived_neurotrophic_factor

  • Dehydroepiandrosterone sulfate

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone sulfate

    Dehydroepiandrosterone_sulfate

  • Neurotrophic keratitis

    • Medical condition

    in NK patients. A recombinant human NGF (rhNGF) eye drop formulation, cenegermin, has been developed for clinical use and has recently been approved in

    Neurotrophic keratitis

    Neurotrophic_keratitis

  • ACD856

    • TrkA and TrkB positive modulator

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    ACD856

    ACD856

  • Cerebrolysin

    • Experimental drug for neurodegenerative disorders

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Cerebrolysin

    Cerebrolysin

  • Osimertinib

    • Chemical compound, used as a medication to treat lung cancer

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Osimertinib

    Osimertinib

    Osimertinib

  • Cabozantinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Cabozantinib

    Cabozantinib

    Cabozantinib

  • Antineoplastic

    • Class of drugs used to treat malignant tumors

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Antineoplastic

    Antineoplastic

    Antineoplastic

  • Pertuzumab/trastuzumab/hyaluronidase

    • Combination drug

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Pertuzumab/trastuzumab/hyaluronidase

    Pertuzumab/trastuzumab/hyaluronidase

  • Epidermal growth factor

    • Protein that stimulates cell division and differentiation

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Epidermal growth factor

    Epidermal growth factor

    Epidermal_growth_factor

  • Cetuximab

    • Pharmaceutical drug

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Cetuximab

    Cetuximab

    Cetuximab

  • ATC code S01

    • Pharmaceutical drug classification

    preparations S01XA21 Mercaptamine S01XA22 Ocriplasmin S01XA23 Sirolimus S01XA24 Cenegermin S01XA25 Lifitegrast S01XA26 Riboflavin S01XA27 Voretigene neparvovec S01XA28

    ATC code S01

    ATC_code_S01

  • Repotrectinib

    • Medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Repotrectinib

    Repotrectinib

    Repotrectinib

  • Fibroblast growth factor receptor 3

    • Gene involved in the most common form of dwarfism

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Fibroblast growth factor receptor 3

    Fibroblast growth factor receptor 3

    Fibroblast_growth_factor_receptor_3

  • Trastuzumab

    • Medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Trastuzumab

    Trastuzumab

    Trastuzumab

  • Receptor tyrosine kinase

    • Class of enzymes

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Receptor tyrosine kinase

    Receptor tyrosine kinase

    Receptor_tyrosine_kinase

  • Fruquintinib

    • Medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Fruquintinib

    Fruquintinib

    Fruquintinib

  • Fibroblast growth factor 2

    • Growth factor and signaling protein otherwise known as FGF2

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Fibroblast growth factor 2

    Fibroblast growth factor 2

    Fibroblast_growth_factor_2

  • List of drugs granted breakthrough therapy designation

    • Alnylam Pharmaceuticals hereditary transthyretin-mediated amyloidosis Cenegermin Dompe Farmaceutici neurotrophic keratitis Lanadelumab Takeda Pharmaceuticals

    List of drugs granted breakthrough therapy designation

    List_of_drugs_granted_breakthrough_therapy_designation

  • Tavilermide

    • Chemical compound

    I clinical trials for the treatment of glaucoma; studies are ongoing. Cenegermin Meerovitch K, Torkildsen G, Lonsdale J, Goldfarb H, Lama T, Cumberlidge

    Tavilermide

    Tavilermide

    Tavilermide

  • Pegfilgrastim

    • Monoclonal antibody

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Pegfilgrastim

    Pegfilgrastim

  • Encorafenib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Encorafenib

    Encorafenib

    Encorafenib

  • Nintedanib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Nintedanib

    Nintedanib

    Nintedanib

  • Avutometinib/defactinib

    • Combination cancer medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Avutometinib/defactinib

    Avutometinib/defactinib

  • Insulin-like growth factor 1 receptor

    • Cell receptor protein found in humans

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Insulin-like growth factor 1 receptor

    Insulin-like growth factor 1 receptor

    Insulin-like_growth_factor_1_receptor

  • Neurotrophic factors

    • Family of biomolecules

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Neurotrophic factors

    Neurotrophic_factors

  • Trastuzumab emtansine

    • Pharmaceutical drug

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Trastuzumab emtansine

    Trastuzumab emtansine

    Trastuzumab_emtansine

  • Dasatinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Dasatinib

    Dasatinib

    Dasatinib

  • Lenvatinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Lenvatinib

    Lenvatinib

    Lenvatinib

  • Platelet-derived growth factor

    • Signaling glycoprotein regulating cell proliferation

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Platelet-derived growth factor

    Platelet-derived growth factor

    Platelet-derived_growth_factor

  • Imatinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Imatinib

    Imatinib

    Imatinib

  • Dihexa

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Dihexa

    Dihexa

    Dihexa

  • KIT gene

    • Mammalian protein and protein-coding gene

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    KIT gene

    KIT gene

    KIT_gene

  • Ranibizumab

    • Pharmaceutical drug

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Ranibizumab

    Ranibizumab

  • Lapatinib

    • Cancer medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Lapatinib

    Lapatinib

    Lapatinib

  • EPH receptor B2

    • Protein found in humans

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    EPH receptor B2

    EPH receptor B2

    EPH_receptor_B2

  • Neuregulin

    • Family of four EGF proteins

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Neuregulin

    Neuregulin

    Neuregulin

  • Tyrosine kinase

    • Enzyme

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Tyrosine kinase

    Tyrosine kinase

    Tyrosine_kinase

  • Axitinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Axitinib

    Axitinib

    Axitinib

  • Thrombopoietin

    • Mammalian protein found in Homo sapiens

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Thrombopoietin

    Thrombopoietin

    Thrombopoietin

  • Insulin-like growth factor 2

    • Protein hormone

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Insulin-like growth factor 2

    Insulin-like growth factor 2

    Insulin-like_growth_factor_2

  • Fibroblast growth factor 21

    • Protein-coding gene in mammals

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Fibroblast growth factor 21

    Fibroblast growth factor 21

    Fibroblast_growth_factor_21

  • Trametinib

    • Anticancer medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Trametinib

    Trametinib

    Trametinib

  • Platelet-derived growth factor receptor

    • Cell surface receptors

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Platelet-derived growth factor receptor

    Platelet-derived growth factor receptor

    Platelet-derived_growth_factor_receptor

  • Dabrafenib

    • Anti-cancer medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Dabrafenib

    Dabrafenib

    Dabrafenib

  • PDGFC

    • Protein-coding gene in the species Homo sapiens

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    PDGFC

    PDGFC

    PDGFC

  • Epidermal growth factor receptor

    • Transmembrane protein

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Epidermal growth factor receptor

    Epidermal growth factor receptor

    Epidermal_growth_factor_receptor

  • Ephrin A1

    • Protein found in humans

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Ephrin A1

    Ephrin A1

    Ephrin_A1

  • Sorafenib

    • Cancer treatment medicine

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Sorafenib

    Sorafenib

    Sorafenib

  • Tesevatinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Tesevatinib

    Tesevatinib

    Tesevatinib

  • Dehydroepiandrosterone

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Dehydroepiandrosterone

    Dehydroepiandrosterone

    Dehydroepiandrosterone

  • Fibroblast growth factor receptor 4

    • Protein-coding gene in the species Homo sapiens

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Fibroblast growth factor receptor 4

    Fibroblast growth factor receptor 4

    Fibroblast_growth_factor_receptor_4

  • Ponazuril

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Ponazuril

    Ponazuril

    Ponazuril

  • Tucatinib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Tucatinib

    Tucatinib

    Tucatinib

  • GFRA2

    • Protein-coding gene in the species Homo sapiens

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    GFRA2

    GFRA2

    GFRA2

  • FGF3

    • Protein-coding gene in humans

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    FGF3

    FGF3

    FGF3

  • Ertumaxomab

    • Monoclonal antibody

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Ertumaxomab

    Ertumaxomab

  • IGF-1 LR3

    • Synthetic protein

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    IGF-1 LR3

    IGF-1_LR3

  • Pertuzumab

    • Pharmaceutical drug

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Pertuzumab

    Pertuzumab

    Pertuzumab

  • Semaxanib

    • Chemical compound

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Semaxanib

    Semaxanib

    Semaxanib

  • Hepatocyte growth factor

    • Mammalian protein found in Homo sapiens

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Hepatocyte growth factor

    Hepatocyte growth factor

    Hepatocyte_growth_factor

  • Amivantamab/hyaluronidase

    • Medication

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Amivantamab/hyaluronidase

    Amivantamab/hyaluronidase

  • Hemopoietic growth factor

    • Class of proteins

    (GPE, (1-3)IGF-1) Trofinetide LNGF (p75NTR) Agonists: BDNF BNN-20 BNN-27 Cenegermin DHEA DHEA-S NGF NT-3 NT-4 Antagonists: ALE-0540 Dexamethasone EVT-901

    Hemopoietic growth factor

    Hemopoietic_growth_factor

Affordable travel, tourism, home and auto insurance, legal services

travel, tourism, insurance

Searches for online references containing CENEGERMIN

CENEGERMIN

Search references containing CENEGERMIN

CENEGERMIN

Search queries for Facebook and twitter posts, hashtags with CENEGERMIN

CENEGERMIN

Follow users with usernames @CENEGERMIN or posting hashtags containing #CENEGERMIN

CENEGERMIN

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with CENEGERMIN

CENEGERMIN

Top search, Social media, medium, facebook & news articles containing CENEGERMIN

CENEGERMIN

Searches for Acronyms & meanings containing CENEGERMIN

CENEGERMIN

Searches, Indeed job searches and job offers containing CENEGERMIN

Other words and meanings similar to

CENEGERMIN

Search in online dictionary sources & meanings containing CENEGERMIN

CENEGERMIN

Affordable travel, tourism, home and auto insurance, legal services

travel, tourism, insurance